- Home
- Products
Evrenzo (Roxadustat)
Evrenzo (Roxadustat)
- Medicine Name: Evrenzo
- Generic Name: Roxadustat
- Dosage Form & Strength: Tablets – 20 mg, 50 mg, 70 mg, 100 mg, 150 mg
- Manufactured By: FibroGen, Inc.
Evrenzo (Roxadustat) is an oral anti-anemia medication used in the treatment of symptomatic anemia associated with chronic kidney disease (CKD) in adult patients.
Recommended Dosage (based on hemoglobin levels):
- Typically prescribed three times weekly (e.g., Mon-Wed-Fri).
- Initial dose: 20 mg, titrated up to a maximum of 400 mg T.I.W.
- In some cases, lower frequencies (once/twice weekly) may be advised by a physician.
- Tablet count per dose may vary based on the prescribed strength.
Important: Do not restart or change dosing without physician approval. Hemoglobin levels will be routinely monitored throughout therapy.
Seizures: Use with caution in patients with seizure history or CNS conditions.
Infections: Risk of pneumonia, UTIs. Prompt evaluation and treatment advised.
Thyroid Function: Monitor for symptoms of hypothyroidism. May reverse after stopping the drug.
Liver Function: Not recommended in patients with severe hepatic impairment.
Pregnancy: Contraindicated in the 3rd trimester. Avoid during the 1st and 2nd trimesters.
Breastfeeding: Avoid during lactation due to potential secretion in milk.
Driving or Machinery Use: Use caution as seizures or dizziness may occur.
To import Evrenzo into India, the following documents are mandatory:
- Valid doctor’s prescription
- Diagnostic reports confirming CKD-related anemia
- Government-issued ID of the patient
- Import permit, if required
Order Confirmation is processed only after complete documentation is verified.
GlobalRareMeds, in collaboration with Indian Pharma Network, ensures:
- Global sourcing of Evrenzo from USA, Europe, Canada, Australia
- Dispatched through licensed pharmacists from our fulfillment center in Ambernath, Thane District
- Fast and compliant delivery to your location, following all regulatory protocols
📞 Call/WhatsApp: +91-99675 15602
📧 Email: info@globalraremeds.com
Q. What is Evrenzo used for?
A. Evrenzo is prescribed to treat anemia in adults with chronic kidney disease (CKD).
Q. What strengths does it come in?
A. Available in 20 mg, 50 mg, 70 mg, 100 mg, and 150 mg tablets.
Q. Is Evrenzo FDA-approved?
A. No, but it has been approved in the European Union (EU) since August 2021.
Q. What are common side effects of Evrenzo?
A. Hypertension, peripheral edema, vascular thrombosis, nausea, diarrhea, hyperkalemia.
Q. Can I get Evrenzo in India?
A. Yes, through the Named Patient Import Program. GlobalRareMeds facilitates compliant delivery.
Q. How should it be stored?
A. No special storage conditions required. Store at room temperature away from light.
Q. What is the cost of Evrenzo in India?
A. The price varies based on dose and location. Contact us for a personalized quote.
Q. Is it legal and safe to buy Evrenzo online in India?
A. Yes. Through licensed and WHO-GDP/ISO-certified partners under medical supervision.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
